Abstract
In the last several years, great methodological advances have been made in the field of health economics. This paper covers the contributions of the pharmaceutical industry in making those advances. Now managed care organizations need to incorporate these improved health economics methods into the daily management of their operations. Pharmaceutical companies need to consider where funding for innovative new products will come from in an increasingly limited budgetary environment.
Get full access to this article
View all access options for this article.